Author

David Einspahr

Observed names: D Einspahr, David E Einspahr, David E. Einspahr

Observed institutions: Baylor College of Medicine, Stormont Vail Health

OpenAlex ID: A5004532010

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

2018 · Marina Chiara Garassino, Byoung-Chul Cho, et al. · The Lancet Oncology · 568

Intact transferrin receptors in human plasma and their relation to erythropoiesis

1990 · HA Huebers, Y Beguin, et al. · Blood · 364

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study

2025 · Hani M. Babiker, Vincent Picozzi, et al. · Journal of Clinical Oncology · 48

Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630

2016 · Ronald K Potkul, Joseph M Unger, et al. · npj Breast Cancer · 9

Randomized trial of medroxyprogesterone acetate for prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630.

2016 · Kathy S. Albain, Joseph M. Unger, et al. · Journal of Clinical Oncology

Works count: 5

Citation count: 989

H-index: 4

I10-index: 3